Journal article

Ex Vivo Response to Histone Deacetylase (HDAC) Inhibitors of the HIV Long Terminal Repeat (LTR) Derived from HIV-Infected Patients on Antiretroviral Therapy

Hao K Lu, Lachlan R Gray, Fiona Wightman, Paula Ellenberg, Gabriela Khoury, Wan-Jung Cheng, Talia M Mota, Steve Wesselingh, Paul R Gorry, Paul U Cameron, Melissa J Churchill, Sharon R Lewin

PLoS ONE | PUBLIC LIBRARY SCIENCE | Published : 2014

Grants

Awarded by Australian National Health and Medical Research Council (NHMRC)


Awarded by National Institutes of Health, USA


Awarded by Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE)


Awarded by NHMRC Early Career Fellowship


Awarded by NHMRC Dora Lush biomedical post-graduate scholarship


Funding Acknowledgements

This work was supported by an Australian National Health and Medical Research Council (NHMRC) project grant 1009533 and 1051093; the National Institutes of Health, USA (NIMH100594) and the Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE; U19AI096109). S. R. L. is an NHMRC senior practitioner fellow. P. R. G is supported by an Australian Research Council Future Fellowship (FT2). L. R. G was supported by a NHMRC Early Career Fellowship (GNT0606967). G. K. is a recipient of an NHMRC Dora Lush biomedical post-graduate scholarship (579719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.